700 patients110,866 observations180 daysLIVE

Patient P-02306

Synthetic patientMETA-24 · Day 115 · 55–64 · M · baseline S17Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Favorable
GI state
Improving
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
10%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 startedBaseline state S17
  2. Day 15 Trajectory diverged from predictionObserved response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 15.

Primary contributors, last 14 days
  • GI instability-7
  • Treatment adherence+5
  • Toxicity-3
  • Inflammatory activity-2
  • Nutritional resilience+2

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    Active minutes
    Wearable
    81 min
    stable · -2.1 vs previous 14 d
    Sleep duration
    Wearable
    7.1 h
    stable · +0.1 vs previous 14 d
    Energy level
    Daily log
    6.8/10
    improving · +0.7 vs previous 14 d
    Steps
    Wearable
    8,197
    stable · -92 vs previous 14 d
    GI burden
    Companion
    16.6/100
    improving · -2.6 vs previous 14 d
    Adherence
    Companion
    95.5 %
    stable · +0.9 vs previous 14 d
    Sleep quality
    Wearable
    56.2/100
    improving · +2.0 vs previous 14 d
    Glucose, CGM daily mean
    CGM
    122 mg/dL
    stable · -2.1 vs previous 14 d
    This trajectory is doing well — what to keep, what to watch
    Steering view →

    Heading towards restoration · 78 from the failing basin, 16 from restoration.

    Good elements to keep
    • Protein (supports)
      perturbation · steering +11.1
    • Protein
      supporter · GI -5.8 next day
    Main detractors to watch
    • Low butyrate capacity
      hidden · steering -17.5
    • Alcohol
      perturbation · steering -11.4
    • Dietary fat load
      perturbation · steering -8.6
    • Ultra-processed food
      perturbation · steering -8.1
    • Alcohol
      detractor · GI +5.9 next day
    • Dietary fat load
      detractor · GI +5.1 next day
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Alcohol
      +5.9detractor · 95%
    • Protein
      -5.8supporter · 95%
    • Dietary fat load
      +5.1detractor · 95%
    • Ultra-processed food
      +4.6detractor · 95%
    • Insoluble fibre
      -1.5no signal · 29%
    • Simple carbohydrates
      -1.2no signal · 22%
    • Caffeine
      +1.1no signal · 19%
    • Histamine load
      +0.1no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Inflammatory signalling 45
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
    • Butyrate / short-chain fatty acid production 35
      • MicrobiomeButyrate capacity 22/100
    • Mucosal barrier integrity 30
      • MicrobiomeAkkermansia low → thinner mucus layer
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    • GLP1R rs6923761 A
      Altered receptor sensitivity
    Microbiome
    Shannon diversity 3.1 · butyrate capacity 22/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    60 ms
    Sleep
    6.5 h
    Steps
    9,407
    Resting HR
    64 bpm
    Daily log: GI score 17, nutritional resilience 67, adherence 96.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Eat slowly and stop at comfortable fullness — smaller volume, more often
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the dose at the same time relative to your evening meal
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0221851%S01DT-01improved61
    P-0243737%S0164
    P-0252237%S01BR-03no change40
    P-0262037%S01HY-01improved64
    P-0221736%S0161
    P-0242436%S0162
    P-0227635%S0157
    P-0268135%S0151
    P-0208734%S01BR-03no change40
    P-0237534%S0144
    P-0256834%S0151
    P-0230731%S0155